ArticleClinical lymphoma, myeloma & leukemia2024

Pembrolizumab With R-CHOP in Previously Untreated DLBCL: Sustained, High Efficacy, and Safety With Long-Term Follow-Up.

Carrie Ho et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.